Related Experiment Videos
Lipoma arborescens with hemarthrosis of the knee. A case report
S Edamitsu1, H Mizuta, K Kubota
1Department of Orthopedics, Kumamoto University School of Medicine, Japan.
Acta Orthopaedica Scandinavica
|October 1, 1993
Abstract:
Lipoma arborescens is a rare intraarticular lesion, typically with a clear yellow aspirate. We report a case of lipoma arborescens with hemarthrosis of the knee.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of opium on bladder cancer incidence: A systematic review and meta-analysis.
Actas urologicas espanolas·2025
Acrylamide monomers in universal adhesives.
Dental materials : official publication of the Academy of Dental Materials·2023
Angiopoietin-like protein 2 promotes chondrogenic differentiation during bone growth as a cartilage matrix factor.
Osteoarthritis and cartilage·2017
Articular cartilage degeneration after acute subchondral bone damage: an experimental study in dogs with histopathological grading.
Acta orthopaedica Scandinavica·2005
Alendronate prevents collapse in mechanically loaded osteochondral grafts: a bone chamber study in rats.
Acta orthopaedica Scandinavica·2005
Outcome of surgically treated intraarticular calcaneus fractures--SF-36 compared with AOFAS and MFS.
Acta orthopaedica Scandinavica·2005
Position of the humeral head and rotator cuff tear: an anatomical observation in cadavers.
Acta orthopaedica Scandinavica·2005
The impacted varus (A2.2) proximal humeral fracture: prediction of outcome and results of nonoperative treatment in 99 patients.
Acta orthopaedica Scandinavica·2005
Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study.
Therapeutic advances in neurological disorders·2026
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.
Therapeutic advances in neurological disorders·2026